Combined Immunodeficiency Rag1/2 Knockout Pigs with Severe

Pigs share many physiological, biochemical, and anatomical similarities with humans and have emerged as valuable large animal models for biomedical research. Considering the advantages in immune system resemblance, suitable size, and longevity for clinical practical and monitoring purpose, SCID pigs bearing dysfunctional RAG could serve as important experimental tools for regenerative medicine, allograft and xenograft transplantation, and reconstitution experiments related to the immune system. In this study, we report the generation and phenotypic characterization of RAG1 and RAG2 knockout pigs using transcription activator-like effector nucleases. Porcine fetal fibroblasts were genetically engineered using transcription activator-like effector nucleases and then used to provide donor nuclei for somatic cell nuclear transfer. We obtained 27 live cloned piglets; among these piglets, 9 were targeted with biallelic mutations in RAG1, 3 were targeted with biallelic mutations in RAG2, and 10 were targeted with a monoallelic mutation in RAG2. Piglets with biallelic mutations in either RAG1 or RAG2 exhibited hypoplasia of immune organs, failed to perform V(D)J rearrangement, and lost mature B and T cells. These immunodeficient RAG1/2 knockout pigs are promising tools for biomedical and translational research. The Journal of Immunology , 2014, 193: 000–000. AG1/2 genes encode the enzymes that catalyze the V(D)J recombination of Ig and TCR genes in B and T lymphocyte precursors to generate the diversity of B and T cell primary immune repertoires (1, 2). RAG1 and RAG2 are two adjacent genes in autosomes, and their encoded enzymes function synergistically

[1]  D. Merlin,et al.  Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice. , 2014, Gastroenterology.

[2]  E. Cozzi,et al.  Immunological challenges and therapies in xenotransplantation. , 2014, Cold Spring Harbor perspectives in medicine.

[3]  W. Tian,et al.  Generation of knockout rabbits using transcription activator-like effector nucleases , 2014, Cell Regeneration.

[4]  L. Lai,et al.  Highly Efficient Generation of GGTA1 Biallelic Knockout Inbred Mini-Pigs with TALENs , 2013, PloS one.

[5]  Peng Li,et al.  Generation of RAG 1- and 2-deficient rabbits by embryo microinjection of TALENs , 2013, Cell Research.

[6]  Huimin Zhao,et al.  Transcription activator‐like effector nucleases (TALENs): A highly efficient and versatile tool for genome editing , 2013, Biotechnology and bioengineering.

[7]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[8]  Ignacio Anegon,et al.  Generation of Rag1‐knockout immunodeficient rats and mice using engineered meganucleases , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Daniel F. Voytas,et al.  Efficient TALEN-mediated gene knockout in livestock , 2012, Proceedings of the National Academy of Sciences.

[10]  Y. Kashiwakura,et al.  Il2rg gene-targeted severe combined immunodeficiency pigs. , 2012, Cell stem cell.

[11]  Ya-Jen Chang,et al.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.

[12]  Erin L. Doyle,et al.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.

[13]  Elo Leung,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[14]  I. Weissman,et al.  T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell , 2010, Proceedings of the National Academy of Sciences.

[15]  R. Buckley,et al.  Why Newborn Screening for Severe Combined Immunodeficiency Is Essential: A Case Report , 2010, Pediatrics.

[16]  Shihua Li,et al.  Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. , 2010, Human molecular genetics.

[17]  J. Leigh,et al.  Early, microbially driven follicular reactions in the neonatal piglet do not contribute to expansion of the immunoglobulin heavy chain V-D-J repertoire. , 2007, Veterinary immunology and immunopathology.

[18]  Markus G. Manz,et al.  Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.

[19]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[20]  A. Fischer,et al.  The mechanisms of immune diversification and their disorders , 2003, Nature Reviews Immunology.

[21]  R. Flavell,et al.  Immune-Mediated Eradication of Tumors through the Blockade of Transforming Growth Factor-beta Signaling in T Cells , 2002 .

[22]  E. Brooks,et al.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. , 2001, Blood.

[23]  Sandro Santagata,et al.  Partial V(D)J Recombination Activity Leads to Omenn Syndrome , 1998, Cell.

[24]  U. Pannicke,et al.  RAG Mutations in Human B Cell-Negative SCID , 1996, Science.

[25]  Christina A. Cuomo,et al.  Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps , 1995, Cell.

[26]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[27]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[28]  D. Schatz,et al.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. , 1990, Science.